Cancers of the central nervous system remain to be the grande challenge in cancer therapy. The aiPTO team has developed clinically validated predictive patient avatar models and trained generative AI models capable of predicting patient responses. With these disruptive technologies, aiPTO Techbio is dedicated to revolutionizing the CNS cancer R&D ecosystem and ultimately providing effective therapeutics to CNS cancer patients.